Search Results - "Yasasever, V"

Serum caveolin-1 and fibronectin levels as clinical markers for patients with malignant melanoma by Tilgen Yasasever, C, Bilgin Doğru, E, Serilmez, M, Taș, F, Yasasever, V

Get full text

Clinical significance of caveolin-1 and fibronectin in pancreatic cancer by Bilgin Doğru, E, Tilgen Yasasever, C, Serilmez, M, Dağoğlu, N, Yasasever, V

Get full text

The biological role of AKT serine/threonine kinase 2 in lung cancer by Serilmez, M, Karaman, S, Oguz Soydinc, H, Tilgen Yasasever, C, Bilgin, E, Duranyildiz, D, Yasasever, V

Get full text

Clinical significance of interleukin-4 and interleukin-18 levels in aggressive non-Hodgkin's lymphoma patients by Soydinc, H O, Guney, N, Basaran, M, Duranyildiz, D, Yasasever, V

“…Strong evidence indicates that tumor growth can be actively controlled by the immune system, and interleukins (ILs) are known to play an influential role in…”
Get full text

Clinical significance of serum hepatocyte growth factor (HGF) levels in hepatocellular carcinoma by Karabulut, S., Tas, F., Akyüz, F., Ormeci, A. C., Serilmez, M., Soydinç, H. O., Vatansever, S., Yasasever, V.

“…Hepatocellular carcinoma (HCC) is the commonest primary malignant cancer of the liver in the world. This study was conducted to investigate the serum levels of…”
Get full text

Angiogenic factors in breast cancer by Yasasever, V, Soydinc, H. Oguz, Camlica, H, Duranyildiz, D, Dalay, N

Get full text

Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer by Tas, F, Aydiner, A, Topuz, E, Yasasever, V, Karadeniz, A, Saip, P

“…The aim of this study is to assess the clinical usefulness of serum assays of carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCC), and CYFRA…”
Get more information

Prognostic significance of melanoma inhibiting activity levels in malignant melanoma by Meral, R, Duranyildiz, D, Tas, F, Camlica, H, Yasasever, V, Kurul, S, Dalay, N

“…This analytic (phase II) study aimed to investigate the hypothesis that the decline in serum melanoma-inhibiting activity (MIA) levels following initiation of…”
Get full text

1200A - Serum caveolin-1 and fibronectin levels as clinical markers for patients with malignant melanoma by Tilgen Yasasever, C., Bilgin Doğru, E., Serilmez, M., Taș, F., Yasasever, V.

Get full text

1332A - The biological role of AKT serine/threonine kinase 2 in lung cancer by Serilmez, M., Karaman, S., Oguz Soydinc, H., Tilgen Yasasever, C., Bilgin, E., Duranyildiz, D., Yasasever, V.

Get full text

610A - Clinical significance of caveolin-1 and fibronectin in pancreatic cancer by Bilgin Doğru, E., Tilgen Yasasever, C., Serilmez, M., Dağoğlu, N., Yasasever, V.

Get full text

Telomerase activity in patients with chronic myeloid leukemia and lymphoma by Bitisik, O, Yavuz, S, Yasasever, V, Dalay, N

“…Telomeres are repeated DNA sequences, positioned at the ends of chromosomes and are essential for the stable maintenance of chromosomes. The telomere length…”
Get more information

The value of TPS in breast cancer by Karaloglu, D, Yasasever, V, Ertürk, N, Dalay, N

“…The serum concentration of the cell proliferation marker TPS (Tissue Polypeptide-Specific Antigen) was compared with 7 different common tumor markers (CEA, CA…”
Get more information

Diagnostic value of the tumor markers in breast cancer by Yasasever, V, Karaloglu, D, Ertürk, N, Dalay, N

“…The use of the most common tumor markers in breast cancer was reassessed in terms of cost effectiveness and the validity of their predictive information during…”
Get more information

Evaluation of phosphohexose isomerase as a metastasis marker in breast cancer patients by Yasasever, V, Dinçer, M, Camlica, H, Duranyildiz, D, Dalay, N

“…In this study the value of PHI serum measurements in breast cancer as an index of metastases was investigated. Serum CA 15-3 and CEA tumor marker and…”
Get more information

Osteocalcin: a valuable bone metastasis marker by Onat, H, Yasasever, V, Sengün, Z, Dalay, N

“…Osteocalcin (BCG) in an osteoblast product which reflects the bone formation rate. It could be a valuable bone metastasis marker. To investigate this, we…”
Get more information

Prognostic and predictive value of vascular endothelial growth factor and soluble flt-1 and kdr levels in the sera of small cell lung cancer patients by Ustuner, Z., Saip, P., Yasasever, V., Ozturk, B., Vural, B., Ozbek, U., Topuz, E.

“…Abstract only 21152 Background: Small cell lung cancer (SCLC) has a rapid growth rate, and is characterized by early metastases. Tumor growth is dependent on…”
Get full text

Menstrual cycle values of tumor marker in healthy women and in patients with non-gynecological tumors by Yasasever, V, Bilge, N, Töre, G, Onat, H, Enginún, M

“…The aim of the present study is to investigate whether the values of CA 12-5 which is considered a specific ovarian tumor marker can be used in patients with…”
Get more information

TUMOR MARKERS IN MOLECULAR MEDICINE by Oğuz, H, Yasasever, V

“…Tümör oluşumunda, normal hücrenin transforme hücre haline geçişi sırasında birçok biyokimyasal olay gerçekleşmektedir. Gerçekleşen biokimyasal olayları takip…”
Get full text

Serum levels of leptin and proinflammatory cytokinesin advanced stage non-small cell lung cancer by Topuz, E., Tas, F., Argon, A., Yildiz, D. D., Oguz, H., Yasasever, V., Eralp, Y., Aydiner, A.

“…Abstract only…”
Get full text